Nadofaragene firadenovec Disease Interactions
There is 1 disease interaction with nadofaragene firadenovec.
Moderate
Nadofaragene firadenovac (applies to nadofaragene firadenovec) immunosuppression
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Immunodeficiency
Nadofaragene firadenovac is a non-replication adenoviral vector-based gene therapy. Patients who are immunocompromised or immunodeficient may be at risk for disseminated adenovirus infection. Avoid exposure to this drug in those patients.
Nadofaragene firadenovec drug interactions
There are 287 drug interactions with nadofaragene firadenovec.
More about nadofaragene firadenovec
- nadofaragene firadenovec consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.